Brand Logo

Engineered for hemodynamic clarity. Supported under ISO 13485, IEC 60601-1, and global post-market controls.

Clinical operations

What I Learned from 200+ ICU Rush Orders: Why Your Patient Monitoring Data Might Be Misleading You

2026-07-13 Jane Smith

If you've ever been in the ICU when a patient crashes, you know that feeling. The numbers are all over the place. The central venous pressure is swinging. The cardiac output looks like a lie. You're asking your team: Is this real, or is it artifact?

I'm a product specialist in the cardiovascular space. For the last five years, I've been on-site for over 200 urgent cases—emergency TAVR implants, post-op bleeds in the CVICU, and, more often than you'd think, a last-minute swap of a monitoring platform because the existing setup just wasn't holding up. Here's what I've found: the biggest killer of clinical confidence isn't the patient's condition. It's bad data.

And the conventional wisdom around 'how to get reliable numbers'? Honestly, most of it is outdated.

The Problem You Think You Have: 'We Need Faster Numbers'

Every time I walk into a new unit and ask what's wrong with their current monitoring, the answer is almost always the same: 'We need more real-time data.' The doctors want continuous cardiac output. The nurses want beat-to-beat stroke volume variation. Everyone thinks the answer is a faster machine.

It makes sense. When a patient is on maximum vasopressors, every second feels critical. You watch the arterial line waveform like a hawk, waiting for it to show that the pressure is coming up. The instinct is: more frequent measurements = better decisions.

But here's the thing I learned the hard way (and by 'the hard way,' I mean standing at the bedside while an attending surgeon looked at me and asked, 'Is this number real?'): faster isn't always more accurate.

The Deeper Issue: You're Measuring the Wrong Thing

The conventional wisdom is that a high-resolution, high-frequency monitor will give you the truth. In my experience—specifically, after a particularly bad night in March 2023 when we had a post-op CABG patient whose cardiac output was reading 'normal' while his lactate was climbing—I realized the truth is messier.

Most traditional monitoring systems (and I won't name names, but you know the ones I'm talking about) rely on algorithms that assume a stable, predictable vascular system. The moment a patient gets vasoplegic, or tachycardic, or starts bleeding, those assumptions fall apart. The monitor keeps spitting out numbers, but those numbers stop reflecting reality.

Put another way: a precise measurement of the wrong variable is worse than a rough estimate of the right one.

This is where the 'Edwards approach'—and I've seen it implemented in maybe 20+ cases now—starts to look different. The focus shifts from 'how fast can we get a number' to 'how reliable is the methodology.' It's about using technologies like thermodilution and calibrated pulse contour analysis, which, frankly, have a much stronger physiological foundation than the uncalibrated, 'plug-and-play' alternatives that a lot of departments default to because they're easier to set up initially.

The Real Cost of Unreliable Data

I've seen teams chase a monitor. They see a drop in stroke volume variation, give a fluid bolus, and… nothing changes. Then they see another number, give more fluids, and the patient ends up volume-overloaded and needing diuretics the next day. That's not just a clinical complication—it's extra ICU days. It's ventilator hours (which, at a major academic center, runs something like $3,000-$5,000 a day).

Based on internal training logs I've reviewed across three different hospital systems over the past year, the single biggest source of 'monitor-induced error' isn't the equipment—it's the interpretation. When the monitor gives you a number that conflicts with the clinical picture, the default tendency is to trust the machine. And if the machine's algorithm was designed for a healthy patient, you've just made a decision based on a faulty premise.

Take it from someone who has watched this happen: a bad monitor doesn't just give you a bad number. It delays the right decision by 20-30 minutes while everyone debates whether the data is real. And in the ICU, twenty minutes is an eternity.

The Solution (It's Not What You Think)

So, what's the fix? It's not about buying the most expensive monitor on the market. And it's definitely not about blaming the nursing staff for 'not using the system right.'

What actually works—and I've seen this in high-performing units that use platforms from Edwards Lifesciences—is building a protocol around measurement integrity. This means:

  • Training that goes beyond 'push this button.' The best teams understand the physiology behind the waveform. When a nurse knows why a thermodilution curve looks abnormal, they don't trust the number. They troubleshoot the catheter placement or the injection technique first.
  • Prioritizing calibrated data over convenience. Yes, a continuous system is nice. But if the patient is unstable, spending the two minutes to do a manual bolus cardiac output calibration can save you hours of chasing ghosts.
  • Having a 'second opinion' layer. In the best-run ICUs, no single number is acted upon in isolation. They cross-reference the monitor data with the venous saturation, the lactate, and the clinical exam. The monitor is a tool, not the truth.

I had a case just last quarter (circa Q3 2024) where a 64-year-old with severe aortic stenosis was crashing post-TAVR. The new, lightweight monitor was showing a cardiac output of 4.0 L/min—totally acceptable. But the nurse (trained on an older Edwards system) didn't trust it. She did a manual calibration, and sure enough, the real number was 2.5. That difference—that willingness to question the machine—changed the entire management plan in that hour.

An informed customer—or in this case, an informed clinical team—makes better decisions. They ask better questions: 'How was that number derived?' instead of 'What's the latest number?'

So, the next time you're evaluating your monitoring setup, or you're on the phone with your vendor (whether it's Edwards or someone else), don't ask about screen refresh rate. Ask about methodology robustness. Ask what happens to the algorithm when the patient's physiology falls outside 'normal.' Because in the real world—the one I've lived in for 200+ emergency cases—that's where the truth lies.

Jane Smith

I’m Jane Smith, a senior content writer with over 15 years of experience in the packaging and printing industry. I specialize in writing about the latest trends, technologies, and best practices in packaging design, sustainability, and printing techniques. My goal is to help businesses understand complex printing processes and design solutions that enhance both product packaging and brand visibility.